Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market – Industry Trends and Forecast to 2027

  • Medical Devices
  • Published Report
  • May 2020
  • MEA
  • 350 Pages
  • No of Tables: 99
  • No of Figures: 24

Middle East & Africa Medical Foods for Inborn Errors of Metabolism Market By Products (Amino Acid, Low Protein Food, Glytactin with GMP Amino Acid-Modified Infant Formula with Iron, Low-Calcium/Vitamin D-Free Infant Formula with Iron, Others), Age Group (Infants, Weaning, Adolescent, Adults), Diseases (Phenylketonuria (PKU), Tyrosinemia Types I and II, Maple Syrup Urine Disease (MSUD), Homocystinuria, Glutaric Acidemia Type I, Urea Cycle Disorders, Methylmalonic Acidemia, Isovaleric Acidemia, Organic Acidurias, Renal Disease, Propionic Acidemia, Disorders of Leucine Metabolism, Others), Form (Powder, Liquids, Others), Packaging (Can, Packets, Bottle, Jar, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Drugs Stores, Online Pharmacies, Others), Country (South Africa, U.A.E, Qatar, Oman, Rest of Middle East and Africa) Industry Trends and Forecast to 2027

Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market Market Analysis and Insights: Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market

Middle East & Africa medical foods for inborn errors of metabolism market are expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with the CAGR of 6.2% in the forecast period of 2020 to 2027 and expected to reach USD 143.64 million by 2027. Increasing incidence of IEM and high disposable income in is helping the market to grow in the forecast period.

Inborn errors of metabolism are congenital disease which is recognized by deficiencies in vital enzymes that are needed to facilitate normal metabolism. Number of diseases have been confirmed and comes in this categories are phenylketonuria (PKU), maple syrup urine disease, homocystinuria, and methylmalonic academia among others. Mainly amino-acid based medical foods are being produced by manufacturers and they are helpful for the treatment of such diseases. Increasing cases of IEM has increased the demand of medical foods and hence revenue generation has increased.

This Medical Foods For Inborn Errors of Metabolism Market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographical expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market Middle East & Africa Medical Foods for Inborn Errors of Metabolism Market Scope and Market Size

Medical foods for inborn errors of metabolism market is segmented into six notable segments which are bifurcated on the basis of products, age group, diseases, form, packaging and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of products, the market is segmented into amino acid, low protein food, glytactin with GMP amino acid-modified infant formula with iron, low-calcium/vitamin D-free infant formula with iron and others. In 2020, amino acid segment is dominating the market as it improves the metabolic activity of patient suffering from inborn errors of metabolism. Amino acids are main source of protein and recommended by the doctors as well.
  • On the basis of age group, the market is segmented into infants, weaning, adolescent and adults. In 2020, infants segment is dominating the market as prevalence of diseases related to IEM is more in infants or in new born.
  • On the basis of diseases, the market is segmented into phenylketonuria (PKU), maple syrup urine disease (MSUD), homocystinuria, methylmalonic acidemia, organic acidurias, propionic acidemia, isovaleric acidemia, disorders of leucine metabolism, glutaric acidemia type I, renal disease, tyrosinemia types I and II, urea cycle disorders and others. In 2020, phenylketonuria (PKU) segment is dominating the market as its incidence is high in all diseases in inborn error of metabolism. High cases of PKU demands for wider range of medical foods for proper treatment and manufacturers are developing products for this disease, thus the segment is dominating the market.
  • On the basis of form, the market is segmented into powder, liquids and others. In 2020, powder form is dominating the market as powder form can be easily consumed and has long shelf life and it is easy in transportation as well.
  • On the basis of packaging, the market is segmented into can, jar, packets, bottle and others. In 2020, can segment is dominating the market as it provide proper safety to the product and it is also easy to maintain its shelf life for long period of time as it has proper air locking.
  • On the basis of distribution channel, the market is segmented into retail pharmacies, hospital pharmacies, drugs stores, online pharmacies and others. In 2020, retail pharmacy segment is dominating the market as the medical foods only taken under prescription by doctors or healthcare professionals. Once the prescription has been given, patients frequently visit retail pharmacies to buy the product.

Middle East & Africa Medical Foods for Inborn Errors of Metabolism Market Country Level Analysis

Middle East & Africa medical foods for inborn errors of metabolism market is analysed and market size information is provided by products, age group, diseases, form, packaging and distribution channel.

The countries covered in the market report are South Africa, UAE, Qatar, Oman, and rest of Middle East and Africa.

South Africa is dominating the market as of high healthcare expenditure in this region and patient are more inclined in taking medical food rather than enzymatic therapy. Along with these, disposable income is high through which it is easy for the patients to afford the medical foods in their daily diet.

The country section of the meat extract market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

The major players covered in the report are Abbott and Nutricia (A Subsidiary of Danone) among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately. 

Customization Available: Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES

TABLE 1 COSTS OF MEDICAL FOODS

TABLE 2 ESTIMATED COSTS PER YEAR FOR MEDICAL FOODS FOR IEM, BY SELECTED AGE GROUP

TABLE 3 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 4 MIDDLE EAST & AFRICA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 5 MIDDLE EAST & AFRICA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 6 MIDDLE EAST & AFRICA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 7 MIDDLE EAST & AFRICA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 8 MIDDLE EAST & AFRICA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 9 MIDDLE EAST & AFRICA LOW PROTEIN FOODS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA INFANTS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA WEANING IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA ADOLESCENT IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA ADULT IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA TYROSINEMIA TYPES I AND II IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA MAPLE SYRUP URINE DISEASE(MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA HOMOCYSTINURIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA GLUTARIC ACIDEMIA TYPE I IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA METHYLMALONIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA ISOVALERIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA ORGANIC ACIDURIAS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA RENAL DISEASE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA PROPIONIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA DISORDERS OF LEUCINE METABOLISM IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA POWDER IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA LIQUID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)

TABLE 39 MIDDLE EAST & AFRICA CAN IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA PACKET IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA BOTTLE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA JAR IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 44 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTON CHANNEL, 2018-2027 (USD MILLION)

TABLE 45 MIDDLE EAST & AFRICA RETAIL PHARMACIES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 46 MIDDLE EAST & AFRICA HOSPITAL PHARMACIES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 47 MIDDLE EAST & AFRICA DRUGS STORES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 48 MIDDLE EAST & AFRICA ONLINE PHARMACIES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 49 MIDDLE EAST & AFRICA OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 50 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 51 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 52 MIDDLE EAST & AFRICA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 53 MIDDLE EAST & AFRICA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 54 MIDDLE EAST & AFRICA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 55 MIDDLE EAST & AFRICA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 56 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)

TABLE 57 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 58 MIDDLE EAST & AFRICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 59 MIDDLE EAST & AFRICA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 60 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 61 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)

TABLE 62 MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 63 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 64 SOUTH AFRICA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 65 SOUTH AFRICA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 66 SOUTH AFRICA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 67 SOUTH AFRICA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 68 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)

TABLE 69 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 70 SOUTH AFRICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 71 SOUTH AFRICA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 72 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 73 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)

TABLE 74 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 75 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 76 SAUDI ARABIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 77 SAUDI ARABIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 78 SAUDI ARABIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 79 SAUDI ARABIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 80 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)

TABLE 81 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 82 SAUDI ARABIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 83 SAUDI ARABIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 84 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 85 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)

TABLE 86 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 87 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 88 OMAN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 89 OMAN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 90 OMAN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 91 OMAN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 92 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)

TABLE 93 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 94 OMAN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 95 OMAN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 96 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 97 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)

TABLE 98 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 99 REST OF MIDDLE EAST & AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions